Home
About
Overview
Sharing Data
ORCID
Help
History (110)
Facial Paralysis
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort.
Hakimelahi, Reza
Erysipeloid
Protocol to assess receptor-ligand binding in C.?elegans using adapted thermal shift assays.
See All 110 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Protocol to assess receptor-ligand binding in C.?elegans using adapted thermal shift assays.
Tse SY, Pukkila-Worley R. Protocol to assess receptor-ligand binding in C.?elegans using adapted thermal shift assays. STAR Protoc. 2023 09 15; 4(3):102477.
View in:
PubMed
subject areas
Animals
Biological Assay
Caenorhabditis elegans
Ligands
authors with profiles
Read Pukkila-Worley MD